EGFR and neoplasm: While the high frequency of the epidermal growth factor receptor (EGFR) is well recognised in triple-negative breast cancers [66], and has been shown to be an independent prognostic factor disease and overall survival [67,68], paradoxically, in one report, low EGFR expression was observed in BRCAmut tumours compared with other TNBCs [69].